Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

ChineseInvestors.com, Inc. (CIIX) Offers Unique Path to Global Chinese Investor and Consumer Market

Founded in 1999, and with offices in the U.S. and China, ChineseInvestors.com, Inc. (OTCQB: CIIX) acts as a growing Chinese-language investment information and services conduit to the global Chinese investor community. Primarily through its websites, the company provides different levels of investment information, both free and via subscription, including information on the U.S. market and […]

Net Element, Inc. (NASDAQ: NETE) Subsidiary PayOnline Adds Russia’s Leading Short-Term Accommodation Rental Service as Client

Before the opening bell, Net Element, Inc. (NASDAQ: NETE) announced that its PayOnline subsidiary has entered into a new partnership with Sutochno.ru, Russia’s premier C2C short-term booking service, through which PayOnline will be providing online payment acceptance services for the platform. Similar to Airbnb, Sutochno.ru gives users the tools to book short-term accommodation in markets […]

GainClients, Inc. (GCLT) has Disruptive Marketing Solutions for Real Estate Professionals

GainClients, Inc. (OTC: GCLT) is disrupting the real estate marketing and advertising industry. Its GCard mobile technology platform ‘allows the loan originator, the real estate sales person, or the “title guy” to succeed in this marketplace’. In an interview with RedChip (http://dtn.fm/ez6tY), CEO of GainClients, Ray Desmond, discussed the concepts behind his company’s business model. […]

Cytosorbents Corp. (NASDAQ: CTSO) Expected to Announce Doubling in Sales for 2016

Cytosorbents Corp. (NASDAQ: CTSO), a critical care-focused immunotherapy company engaged in the research, development, and commercialization of medical devices, most prominently its platform blood purification technology that incorporates a proprietary adsorbent polymer technology, recently pre-announced unaudited results (http://dtn.fm/bKG3F) for fiscal 2016 ahead of its Form 10-K filing. Cytosorbents expects to announce between $8.1 and $8.3 […]

Trevena, Inc. (NASDAQ: TRVN) Completes Phase 3 Apollo Trials for Oliceridine, Says Athena Study on Track

Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company, on January 4 announced it had completed enrollment for its Phase 3 Apollo Pivotal Efficacy Trials of oliceridine for moderate to severe pain. Oliceridine (TRV 130) is Trevena’s lead product candidate. It was deemed “a breakthrough therapy by the U.S. Food and Drug Administration,” based on […]

 

From Our Blog

Market Street Capital Inc. Leverages Expertise to Close the Financing Gap for First-of-a-Kind Energy Deals

August 18, 2026

Every energy technology that eventually becomes “bankable” has to survive an awkward middle stage first, the point where the tech has been proven in a lab or pilot but hasn’t yet run at commercial scale long enough for lenders to trust it. These first-of-a-kind (“FOAK”) projects are demonstration- and deployment-stage projects being brought to final […]

Rotate your device 90° to view site.